These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23815775)

  • 61. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H; Usami O; Xiao P; Gu HX; Hattori T
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):213-8. PubMed ID: 15018709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding.
    el Ahmar W; Poumbourios P; McPhee DA; Kemp BE
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):855-8. PubMed ID: 1720631
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1.
    Lai J; Bernhard OK; Turville SG; Harman AN; Wilkinson J; Cunningham AL
    J Biol Chem; 2009 Apr; 284(17):11027-38. PubMed ID: 19224860
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.
    Huang CC; Lam SN; Acharya P; Tang M; Xiang SH; Hussan SS; Stanfield RL; Robinson J; Sodroski J; Wilson IA; Wyatt R; Bewley CA; Kwong PD
    Science; 2007 Sep; 317(5846):1930-4. PubMed ID: 17901336
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
    Koma T; Yokoyama M; Kotani O; Doi N; Nakanishi N; Okubo H; Adachi S; Adachi A; Sato H; Nomaguchi M
    J Virol; 2021 Jun; 95(13):e0217720. PubMed ID: 33883222
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.
    Valenzuela A; Blanco J; Krust B; Franco R; Hovanessian AG
    J Virol; 1997 Nov; 71(11):8289-98. PubMed ID: 9343181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.
    Yokoyama M; Naganawa S; Yoshimura K; Matsushita S; Sato H
    PLoS One; 2012; 7(5):e37530. PubMed ID: 22624045
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions.
    Ohki K; Kimura T; Jones IM; Morita F; Ikuta K
    Vaccine; 1994 Mar; 12(4):343-50. PubMed ID: 8178557
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop.
    Moore JP; Thali M; Jameson BA; Vignaux F; Lewis GK; Poon SW; Charles M; Fung MS; Sun B; Durda PJ
    J Virol; 1993 Aug; 67(8):4785-96. PubMed ID: 7687303
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 73. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
    Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
    J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120.
    Süsal C; Kirschfink M; Kröpelin M; Daniel V; Opelz G
    Blood; 1996 Mar; 87(6):2329-36. PubMed ID: 8630395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop.
    Tamamis P; Floudas CA
    Biophys J; 2013 Sep; 105(6):1502-14. PubMed ID: 24048002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhancement and induction of HIV-1 infection through an assembled peptide derived from the CD4 binding site of gp120.
    Groß A; Rödel K; Kneidl B; Donhauser N; Mössl M; Lump E; Münch J; Schmidt B; Eichler J
    Chembiochem; 2015 Feb; 16(3):446-54. PubMed ID: 25639621
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
    Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding.
    Stamatatos L; Cheng-Mayer C
    J Virol; 1995 Oct; 69(10):6191-8. PubMed ID: 7545244
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of the potential regions of Epap-1 that interacts with V3 loop of HIV-1 gp120.
    Bhaskar C; Reddy PS; Chandra KS; Sabde S; Mitra D; Kondapi AK
    Biochim Biophys Acta; 2013 Apr; 1834(4):780-90. PubMed ID: 23360764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.